 |
Top 10 Stem cells startups
Updated: April 19, 2024 |
Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide to produce more stem cells. Adult stem cells are frequently used in medical therapies, for example in bone marrow transplantation. Stem cells can now be artificially grown and transformed (differentiated) into specialized cell types with characteristics consistent with cells of various tissues such as muscles or nerves.
1
Country: USA | Funding: $1.3B
Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.
Fate Therapeutics is a stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics.
2
Country: USA | Funding: $1.2B
ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.
ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.
3
Country: USA | Funding: $560M
Century Therapeutics is harnessing the power of adult stem cells to develop curative therapies for cancer. It develops iPSC-derived, allogeneic immune cell therapy products for cancer
Century Therapeutics is harnessing the power of adult stem cells to develop curative therapies for cancer. It develops iPSC-derived, allogeneic immune cell therapy products for cancer
4
Country: USA | Funding: $445M
Rubius is developing a new class of drugs, Red-Cell Therapeutics. Rubius is using advanced cellular therapies that harness the unique, inherent properties of red cells and marry them to the creative power of genetic engineering.
Rubius is developing a new class of drugs, Red-Cell Therapeutics. Rubius is using advanced cellular therapies that harness the unique, inherent properties of red cells and marry them to the creative power of genetic engineering.
5
Country: USA | Funding: $405.9M
Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology. Magenta is focused on improving the patient experience in transplant medicine, with the goal of bringing this lifesaving procedure to more patients.
Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology. Magenta is focused on improving the patient experience in transplant medicine, with the goal of bringing this lifesaving procedure to more patients.
6
Country: USA | Funding: $400M
Celgene spinout that aims is to develop cells from placentas against blood cancers and is founded on the use of stem cells from placentas. The goal is to create therapies across autoimmune and degenerative disease, immuno-oncology, and functional regeneration.
Celgene spinout that aims is to develop cells from placentas against blood cancers and is founded on the use of stem cells from placentas. The goal is to create therapies across autoimmune and degenerative disease, immuno-oncology, and functional regeneration.
7
Country: USA | Funding: $264M
Aspen Neuroscience is a private biotechnology company that uses innovative genomic approaches combined with stem cell biology.
Aspen Neuroscience is a private biotechnology company that uses innovative genomic approaches combined with stem cell biology.
8
Country: USA | Funding: $235.5M
ViaCyte is a leader in the emerging field of regenerative medicine. ViaCyte's innovative product is based on the differentiation of stem cells into pancreatic beta cell precursors, with subcutaneous implantation in a retrievable and immune-protective encapsulation medical device. Once implanted, the precursor cells mature into endocrine cells that secrete insulin and other hormones in a regulated manner to control blood glucose levels. ViaCyte's goal is a product that can free patients with type 1 and type 2 diabetes from long-term insulin dependence.
ViaCyte is a leader in the emerging field of regenerative medicine. ViaCyte's innovative product is based on the differentiation of stem cells into pancreatic beta cell precursors, with subcutaneous implantation in a retrievable and immune-protective encapsulation medical device. Once implanted, the precursor cells mature into endocrine cells that secrete insulin and other hormones in a regulated manner to control blood glucose levels. ViaCyte's goal is a product that can free patients with type 1 and type 2 diabetes from long-term insulin dependence.
9
Country: UK | Funding: $166.4M
We are a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.
We are a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.
10
Country: USA | Funding: $163M
Semma Therapeutics was founded to develop transformative therapies for patients who currently depend on insulin injections.
Semma Therapeutics was founded to develop transformative therapies for patients who currently depend on insulin injections.
Ad
Advertise your startup
11
Country: Belgium | Funding: $149.1M
Promethera Biosciences is a biopharmaceutical company focused on cell therapy products to treat liver diseases.
Promethera Biosciences is a biopharmaceutical company focused on cell therapy products to treat liver diseases.
12
Country: USA | Funding: $138M
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.
13
Country: USA | Funding: $135.5M
QurAlis is specifically focused on discovering & developing new therapies for amyotrophic lateral sclerosis (ALS), the most common form of motor neuron disease.
QurAlis is specifically focused on discovering & developing new therapies for amyotrophic lateral sclerosis (ALS), the most common form of motor neuron disease.
14
Country: USA | Funding: $129.6M
Cellular Dynamics International (CDI), a FUJIFILM company, is a leading developer and manufacturer of human cells used in drug discovery, toxicity testing, stem cell banking, and cell therapy development. The Company partners with innovators from around the world to combine biologically relevant human cells with the newest technologies to drive advancements in medicine and healthier living.
Cellular Dynamics International (CDI), a FUJIFILM company, is a leading developer and manufacturer of human cells used in drug discovery, toxicity testing, stem cell banking, and cell therapy development. The Company partners with innovators from around the world to combine biologically relevant human cells with the newest technologies to drive advancements in medicine and healthier living.
15
Country: USA | Funding: $97.5M
Cellino is on a mission to make personalized, autologous stem cell therapies accessible for patients. Cellino’s platform combines label-free imaging and high-speed laser editing with machine learning to automate cell reprogramming
Cellino is on a mission to make personalized, autologous stem cell therapies accessible for patients. Cellino’s platform combines label-free imaging and high-speed laser editing with machine learning to automate cell reprogramming
16
Country: USA | Funding: $95M
Osiris Therapeutics is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets. The company operates its business through two segments: Therapeutics and Biosurgery segment. The Therapeutics segment focuses on developing biologic stem cell drug candidates from readily available and non-controversial sources. One of its products, Stromagen was used to treat breast cancer in clinical trials.
Osiris Therapeutics is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets. The company operates its business through two segments: Therapeutics and Biosurgery segment. The Therapeutics segment focuses on developing biologic stem cell drug candidates from readily available and non-controversial sources. One of its products, Stromagen was used to treat breast cancer in clinical trials.
17
Country: Israel | Funding: $59.1M
BrainStorm Cell Therapeutics is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD).
BrainStorm Cell Therapeutics is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD).
18
Country: UK | Funding: $48.9M
Mogrify transforms cell therapy by the systematic discovery of novel cell conversions
Mogrify transforms cell therapy by the systematic discovery of novel cell conversions
19
Country: USA
Regenexx focuses on developing breakthrough non-surgical options for people suffering from various orthopedic disorders. We have developed a patent-pending procedure that uses your own stem cells and blood growth factors to regenerate bone and cartilage.
Regenexx focuses on developing breakthrough non-surgical options for people suffering from various orthopedic disorders. We have developed a patent-pending procedure that uses your own stem cells and blood growth factors to regenerate bone and cartilage.
20
Country: USA | Funding: $37.6M
StemoniX is revolutionizing the production, growth, and development of stem cell and stem cell technologies.
StemoniX is revolutionizing the production, growth, and development of stem cell and stem cell technologies.
21
Country: USA
Creative Medical Technology Holdings is a clinical-stage biotechnology company focused on treating erectile dysfunction and stroke using stem cell treatments.
Creative Medical Technology Holdings is a clinical-stage biotechnology company focused on treating erectile dysfunction and stroke using stem cell treatments.
22
Country: USA | Funding: $20.4M
Curi Bio is integrating human iPSC-derived cells, tissue-specific biosystems, and AI-enabled data analytics of new therapeutics.
Curi Bio is integrating human iPSC-derived cells, tissue-specific biosystems, and AI-enabled data analytics of new therapeutics.
23
Country: USA | Funding: $15.9M
We design transformational gene therapies that aim to enhance the body's own defenses to defeat disease.
We design transformational gene therapies that aim to enhance the body's own defenses to defeat disease.
24
Country: Ireland | Funding: €13.4M
Developing first in class regenerative gene therapies. Proprietary OmniSomes technology uses bioengineered stem cell extracellular vesicles (exosomes) as novel delivery vehicles for RNA based advanced therapeutics with regenerative medicine properties.
Developing first in class regenerative gene therapies. Proprietary OmniSomes technology uses bioengineered stem cell extracellular vesicles (exosomes) as novel delivery vehicles for RNA based advanced therapeutics with regenerative medicine properties.
25
Country: Israel | Funding: $4M
KidneyCure's stem cell technology promises to improve quality-of-life for patients with End Stage Renal Disease and to postpone the need for dialysis or kidney transplantation while reducing the financial burden of ESRD treatment on health systems.
KidneyCure's stem cell technology promises to improve quality-of-life for patients with End Stage Renal Disease and to postpone the need for dialysis or kidney transplantation while reducing the financial burden of ESRD treatment on health systems.
26
Country: Canada | Funding: $3.4M
Acorn Biolabs wants consumers to pay them to store genetic material in a bet that the increasing advances in targeted genetic therapies will yield better healthcare results down the line.
Acorn Biolabs wants consumers to pay them to store genetic material in a bet that the increasing advances in targeted genetic therapies will yield better healthcare results down the line.
27
Country: Israel
REGENECURE specializes in the development of biomaterials and bone tissue engineering focusing on the design, manufacture, and marketing of innovative products for the global orthopedic and dental surgery markets. Our products provide guided bone regeneration for applications in trauma, spine, and reconstructive cranial and facial orthopedics.
REGENECURE specializes in the development of biomaterials and bone tissue engineering focusing on the design, manufacture, and marketing of innovative products for the global orthopedic and dental surgery markets. Our products provide guided bone regeneration for applications in trauma, spine, and reconstructive cranial and facial orthopedics.
28
Country: UK | Funding: £1.5M
Cell Guidance Systems is a biotechnology company developing research tools for stem cell technology.
Cell Guidance Systems is a biotechnology company developing research tools for stem cell technology.
29
Country: India
Advancells is a research oriented company focused on therapeutic applications of Regenerative Medicine. One of the pioneers Stem Cell Company in India, we are passionate about the almost limitless potential of Human Stem Cells in providing a natural cure for any ailment that our body suffers from.
Advancells is a research oriented company focused on therapeutic applications of Regenerative Medicine. One of the pioneers Stem Cell Company in India, we are passionate about the almost limitless potential of Human Stem Cells in providing a natural cure for any ailment that our body suffers from.
30
Country: Netherlands
Glycostem is a clinical-stage company, harvesting the power of allogeneic cells like Natural Killer (NK) cells or antigen presenting cell in the field of cellular cancer immunotherapy.
Glycostem is a clinical-stage company, harvesting the power of allogeneic cells like Natural Killer (NK) cells or antigen presenting cell in the field of cellular cancer immunotherapy.
31
Country: Germany
denovoMATRIX offers modular biomimetic matrices that can be tailored to recreate a large variety of extracellular matrices for any cell type.
denovoMATRIX offers modular biomimetic matrices that can be tailored to recreate a large variety of extracellular matrices for any cell type.
32
Country: Switzerland
Research and development in Stem Cell and Regenerative medicine.
Research and development in Stem Cell and Regenerative medicine.
33
Country: USA
Oscine Therapeutics is harnessing the power of stem cell science to revolutionize treatment of CNS diseases
Oscine Therapeutics is harnessing the power of stem cell science to revolutionize treatment of CNS diseases